Abstract
In patients undergoing endovascular therapy for acute ischemic stroke, antithrombotic therapies are utilized to prevent distal embolization, arterial reocclusion, or catheter-related embolism. However, this must be weighed against the risk of hemorrhagic complications secondary to existing and ongoing ischemia or silent vessel perforation. In this article, we present an overview of the available literature evaluating antithrombotic therapy in patients undergoing endovascular therapy for acute ischemic stroke and discuss the emerging role of these agents. Neurology
Original language | English (US) |
---|---|
Pages (from-to) | S174-S181 |
Journal | Neurology |
Volume | 79 |
Issue number | 13 SUPPL. 1 |
DOIs | |
State | Published - Sep 25 2012 |
Externally published | Yes |
ASJC Scopus subject areas
- Clinical Neurology